GB Patent

GB9801690D0 — Therapeutic agents

Assigned to Pfizer Ltd Great Britain · Expires 1998-03-25 · 28y expired

What this patent protects

Compounds of formula (I): <CHEM> where the substituents are as defined herein, and salts thereof, are matrix metalloprotease inhibitors.

USPTO Abstract

Compounds of formula (I): <CHEM> where the substituents are as defined herein, and salts thereof, are matrix metalloprotease inhibitors.

Drugs covered by this patent

Patent Metadata

Patent number
GB9801690D0
Jurisdiction
GB
Classification
—
Expires
1998-03-25
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Ltd Great Britain
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.